News, Weather and Classifieds for Southern New England
Memorial Hospital of Rhode Island is now offering Vagus Nerve Stimulation (VNS) Therapy, the only FDA-approved device treatment option for epilepsy.
Epilepsy is the third most common neurological disorder in the U.S., affecting over 3 million Americans of all ages. The primary treatment option for epilepsy is medication, but two-thirds of patients have seizures that cannot be controlled by medication alone.
In 1997, a new treatment option designed to help these patients first became available. VNS Therapy is an implantable device that indirectly delivers mild electrical impulses to the brain via the vagus nerve in the neck to prevent, or mitigate, seizures. Neurostimulation revolutionized the treatment of epilepsy. With the introduction of VNS Therapy, epilepsypatients were offered a completely new option, and, for many, new hope.
To date, VNS Therapy technology has:
- Been used to treat more than 70,000 epilepsy patients worldwide
- Evolved through five generations to become smaller, have a longer battery life and provide advanced functionality
To learn more about VNS Therapy as a treatment option for
refractory epilepsy, contact Charles Kanaly, MD, at (401) 273-4155.
More Information:Click here for an issue overviewClick here to learn more how VNS Therapy works